Latest filing published 22 Jan 2026 for NewAmsterdam Pharma Co N.V., €479k. Read the official filing
Mayur Ian Somaiya appears in our data through filings on NewAmsterdam Pharma Co N.V. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 7 January 2025 to 20 January 2026.
On the market, this insider has only sold: 1 sale, €145k in total. The rest of the record consists of 1 share grant and 2 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 22 January 2026, the filings show an option exercise worth €479k in NewAmsterdam Pharma Co N.V. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations